SCHEMBL7547754

SCHEMBL7547754

CC(C)(C)OC(=O)n1c2c(c3cc(N)ccc31)CCCC2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 5/20 0.55
NR1H2 P55055 2/20 0.44
PTGS1 P23219 2/20 0.41
PTGS2 P35354 2/20 0.41
HSD17B10 Q99714 1/20 0.40
CCNB2 O95067 1/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
GSK3B P49841 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
ALOX5 P09917 1/20 0.39
TSHR P16473 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
GABRA5 P31644 2/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7488308 0.85 CCNB2 (0.53) HTR6NR1H2PTGS1PTGS2HSD17B10
SCHEMBL28883032 0.82 TSHR (0.55) HSD17B10TSHRALDH1A1KDM4EMEN1
SCHEMBL6482125 0.80 HTR6 (0.56) HTR6PTGS1PTGS2HSD17B10ALOX5
SCHEMBL31716058 0.78 CCNB2 (0.43) HTR6NR1H2HSD17B10CCNB2CDK1
SCHEMBL6483062 0.76 CHRM2 (0.49) HTR6NR1H2HSD17B10CCNB2CDK1
SCHEMBL31716619 0.75 TSHR (0.38) HTR6NR1H2HSD17B10TSHRALDH1A1
SCHEMBL31716314 0.75 KDM4E (0.41) NR1H2HSD17B10TSHRALDH1A1KDM4E
SCHEMBL28808534 0.72 NR1H2 (0.40) HTR6NR1H2CCNB2CDK1CCNB1
SCHEMBL28808533 0.72 GABRG2 (0.43) HTR6NR1H2CCNB2CDK1CCNB1
SCHEMBL10152246 0.71 HSD17B10 (0.76) HTR6HSD17B10KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1248777-A2 TRICYCLIC COMPOUNDS WITH ANTIVIRAL ACTIVITY WARNER-LAMBERT COMPANY (US) 2002-10-16 EP disclosed
WO-2001051479-A2 TRICYCLIC COMPOUNDS WITH ANTIVIRAL ACTIVITY WARNER-LAMBERT COMPANY (US) 2001-07-19 WO disclosed